Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2025-12-25 @ 3:10 PM
Study NCT ID:
NCT03580668
Status:
COMPLETED
Last Update Posted:
2024-06-18
First Post:
2018-06-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-03
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-26
First Submit QC Date:
None
Study First Post Date:
2018-07-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-14
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL